Factors influencing the indocyanine green (ICG) test: Additional impact of acute cholestasis

Hepato-Gastroenterology

Volumn 56, Issue 91-92, 2009, Pages 734-738

  Stockmann, Martin ^a   Malinowski, Maciej ^a   Lock, Johan F ^a   Seehofer, Daniel ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endoscopic intervention; Liver function; Obstructive jaundice

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; INDOCYANINE GREEN;

AGED; ANIMAL EXPERIMENT; ARTICLE; BILE DUCT LIGATION; BILIARY TRACT SURGERY; CASE REPORT; CHOLESTASIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGED; ANIMALS; CHOLESTASIS; COLORING AGENTS; DISEASE MODELS, ANIMAL; HUMANS; INDOCYANINE GREEN; JAUNDICE, OBSTRUCTIVE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS;

EID: 67651219589     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fox IJ, Brooker LG, Heseltine DW, et al: A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Mayo Clin Proc 1957; 32:478-484.
2. Cherrick GR, Stein SW, Leevy CM, et al: Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960; 39:592-600.
3. Leevy CM, Smith F, Longueville J, et al: Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. Jama 1967; 200:236-240.
4. Imamura H, Sano K, Sugawara Y, et al: Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005; 12:16-22. (Pubitemid 40378835)
5. Mullin EJ, Metcalfe MS, Maddern GJ: How much liver resection is too much? Am J Surg 2005; 190:87-97.
6. Koeppel TA, Trauner M, Baas JC, et al: Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology 1997; 26:1085-1091. (Pubitemid 27509287)
7. Imai T, Takahashi K, Goto F, et al: Measurement of blood concentration of indocyanine green by pulse dye densitometry-comparison with the conventional spectrophotometric method. J Clin Monit Comput 1998; 14:477-484. (Pubitemid 29129280)
8. Mizushima Y, Tohira H, Mizobata Y, et al: Assessment of effective hepatic blood flow in critically ill patients by noninvasive pulse dye-densitometry. Surg Today 2003; 33:101-105. (Pubitemid 36269377)
9. Seehofer D, Stockmann M, Schirmeier A, et al: Intraabdominal bacterial infections significantly alter regeneration and function of the liver in a rat model of major hepatectomy. Langenbecks Arch Surg 2007; 392:273-284. (Pubitemid 46675807)
10. Paumgartner G: The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975; 105:1-30.
11. Bennett JJ, Blumgart LH: Assessment of hepatic reserve prior to hepatic resection. J Hepatobiliary Pancreat Surg 2005; 12:10-15. (Pubitemid 40378834)
12. Albers I, Hartmann H, Bircher J, et al: Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24:269-276. (Pubitemid 19110881)
13. Kusaka K, Harihara Y, Torzilli G, et al: Objective evaluation of liver consistency to estimate hepatic fibrosis and functional reserve for hepatectomy. J Am Coll Surg 2000; 191:47-53. (Pubitemid 30439558)
14. Fan ST, Wang QS, Lo CM, et al: Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction. Aust N Z J Surg 1994; 64:759-762. (Pubitemid 24338935)
15. Bauer LA, Stenwall M, Horn JR, et al: Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy. Clin Pharmacol Ther 1986; 40:239-242. (Pubitemid 16048889)
16. Sharpe DA, Mitchel IM, Kay EA, et al: Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine. Perfusion 1999; 14:29-36. (Pubitemid 29070650)
17. Sakka SG: Indocyanine green plasma disappearance rate during relief of increased abdominal pressure. Intensive Care Med 2006; 32:2090-2091. (Pubitemid 44833134)
18. Stehr A, Ploner F, Traeger K, et al: Plasma disappearance of indocyanine green: a marker for excretory liver function? Intensive Care Med 2005; 31:1719-1722.
19. Hunton DB, Bollman JL, Hoffman HN, 2nd: The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents. J Clin Invest 1961; 40:1648-1655.
20. Kimura T, Nakayama S, Yamao T, et al: Pharmacokinetics of indocyanine green in rats with experimentally induced hepatic diseases. Biol Pharm Bull 1993; 16:1140-1145. (Pubitemid 24014442)
21. Melzer E, Krepel Z, Ronen I, et al: Recovery of hepatic clearance and extraction following a release of common bile duct obstruction in the rat. Res Exp Med (Berl) 1992; 192:35-40.
22. Takaya S, Iwatsuki S, Noguchi T, et al: The influence of liver dysfunction on cyclosporine pharmacokinetics - a comparison between 70 per cent hepatectomy and complete bile duct ligation in dogs. Jpn J Surg 1989; 19:49-56. (Pubitemid 19091495)
23. Baumgartner U, Scholmerich J, Feuerstein E, et al: Repetitive short-term bile duct obstruction and relief causes reproducible and reversible bile acid regurgitation. J Surg Res 2003; 110:222-227. (Pubitemid 36403712)
24. Cotting J, Zysset T, Reichen J: Biliary obstruction dissipates bioelectric sinusoidal-canalicular barrier without altering taurocholate uptake. Am J Physiol 1989; 256:G312- 318. (Pubitemid 19064233)